Randomized Comparison of Continuous Versus Intermittent Heparin Infusion During Catheter Ablation of Atrial Fibrillation

Spragg, 2008, Complications of catheter ablation for atrial fibrillation: incidence and predictors, J Cardiovasc Electrophysiol, 19, 627, 10.1111/j.1540-8167.2008.01181.x Scherr, 2009, Incidence and predictors of periprocedural cerebrovascular accident in patients undergoing catheter ablation of atrial fibrillation, J Cardiovasc Electrophysiol, 20, 1357, 10.1111/j.1540-8167.2009.01540.x Verma, 2012, The use of anticoagulation during the periprocedure period of atrial fibrillation ablation, Curr Opin Cardiol, 27, 55, 10.1097/HCO.0b013e32834dc34d Ren, 2004, Left atrial thrombus associated with ablation for atrial fibrillation: identification with intracardiac echocardiography, J Am Coll Cardiol, 43, 1861, 10.1016/j.jacc.2004.01.031 Calkins, 2012, Heart Rhythm, 9, 632, 10.1016/j.hrthm.2011.12.016 Hirsh, 2001, American Heart A. Guide to anticoagulant therapy: heparin: a statement for healthcare professionals from the American Heart Association, Circulation, 103, 2994, 10.1161/01.CIR.103.24.2994 Mehran, 2011, Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium, Circulation, 123, 2736, 10.1161/CIRCULATIONAHA.110.009449 Di Biase, 2014, Circulation, 129, 2638, 10.1161/CIRCULATIONAHA.113.006426 Lakkireddy, 2012, Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry, J Am Coll Cardiol, 59, 1168, 10.1016/j.jacc.2011.12.014 Kim, 2013, Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation, Heart Rhythm, 10, 483, 10.1016/j.hrthm.2012.12.011 Bassiouny, 2013, Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation, Circ Arrhythm Electrophysiol, 6, 460, 10.1161/CIRCEP.113.000320 Winkle, 2014, Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban, Europace, 16, 1443, 10.1093/europace/euu196 Konduru, 2012, Differences in intraprocedural ACTs with standardized heparin dosing during catheter ablation for atrial fibrillation in patients treated with dabigatran vs. patients on uninterrupted warfarin, J Interv Card Electrophysiol, 35, 277, 10.1007/s10840-012-9719-9 Chang, 1998, How does warfarin affect the activated coagulation time?, Am Heart J, 136, 477, 10.1016/S0002-8703(98)70223-6 Hamam, 2013, Impact of international normalized ratio and activated clotting time on unfractionated heparin dosing during ablation of atrial fibrillation, Circ Arrhythm Electrophysiol, 6, 491, 10.1161/CIRCEP.113.979088 Herrera Siklody, 2011, Incidence of asymptomatic intracranial embolic events after pulmonary vein isolation: comparison of different atrial fibrillation ablation technologies in a multicenter study, J Am Coll Cardiol, 58, 681, 10.1016/j.jacc.2011.04.010 Gaita, 2010, Radiofrequency catheter ablation of atrial fibrillation: a cause of silent thromboembolism? Magnetic resonance imaging assessment of cerebral thromboembolism in patients undergoing ablation of atrial fibrillation, Circulation, 122, 1667, 10.1161/CIRCULATIONAHA.110.937953 Haeusler, 2013, 3 Tesla MRI-detected brain lesions after pulmonary vein isolation for atrial fibrillation: results of the MACPAF study, J Cardiovasc Electrophysiol, 24, 14, 10.1111/j.1540-8167.2012.02420.x Di Biase, 2014, Heart Rhythm, 11, 791, 10.1016/j.hrthm.2014.03.003